Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient.
about
Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversiesNon-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and managementFrom targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumorsHereditary genodermatoses with cancer predispositionEndocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromesPancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathwayGastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations.A case of pancreatic neuroendocrine tumor in a patient with neurofibromatosis-1Genetics of pancreatic neuroendocrine tumors: implications for the clinic.Pancreatic insulinoma co-existing with gastric GIST in the absence of neurofibromatosis-1.Neuroendocrine tumors and tumor syndromes in childhood.Pathology diagnosis of pancreatic neuroendocrine tumors.NETs: organ-related epigenetic derangements and potential clinical applications.When should genetic testing be performed in patients with neuroendocrine tumours?Pseudoangiomatous stromal hyperplasia with multinucleated stromal giant cells is neither exceptional in gynecomastia nor characteristic of neurofibromatosis type 1.The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?A Clinical Roadmap to Investigate the Genetic Basis of Pediatric Pheochromocytoma: Which Genes Should Physicians Think About?Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumours
P2860
Q24647838-4CCC73BC-3EFA-4420-8401-9F4A5F0A0708Q26795597-F29E8E11-6B6A-4083-9CFE-2146C4781372Q26822011-BEBBB5BA-C43D-473A-907D-32C34CA80E8FQ30470596-510B99C0-3F1A-4882-9707-1A0FA3E0EE07Q30475253-90934BCB-64FE-44FB-95D8-914429F518CEQ34887795-785DA349-1024-43D9-AEC0-3DF2138E7FC1Q36358065-F0AC04AC-A091-4911-A167-1055C20BC9F3Q36535847-5AA13C83-AD99-421E-A45E-724B3AA09874Q36960581-B2F7EC62-A046-4A4D-A019-6DC93272F847Q37117324-05C55E59-7EF4-4064-9FDB-FA13F5D0D5EAQ37587164-F8D804D5-5D1F-450C-8767-38BDEB620AF0Q38340420-13427B1B-9AA9-4821-BD39-DD1A277E8FDDQ38841735-86DAA8B7-7A8E-4931-AA3B-74C506DDC59DQ47921456-053DF2FA-0CEC-41F0-8C98-E2A37092D9DBQ53644724-BAFA9BB1-52CB-4C4E-8A39-A81FF28A966BQ54122937-714782C4-36B8-4B00-85FF-22D7A37DBFB1Q55263855-C3E7757B-E0DA-4EBA-AC5B-B776FDDC0747Q55981792-E0621DFC-0377-47F5-A490-2B54DEBF547A
P2860
Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Pancreatic endocrine tumors ar ...... insulinoma in a NF-1 patient.
@en
Pancreatic endocrine tumors ar ...... insulinoma in a NF-1 patient.
@nl
type
label
Pancreatic endocrine tumors ar ...... insulinoma in a NF-1 patient.
@en
Pancreatic endocrine tumors ar ...... insulinoma in a NF-1 patient.
@nl
altLabel
Pancreatic Endocrine Tumors ar ...... ofibromatosis Type 1 Phenotype
@en
prefLabel
Pancreatic endocrine tumors ar ...... insulinoma in a NF-1 patient.
@en
Pancreatic endocrine tumors ar ...... insulinoma in a NF-1 patient.
@nl
P2093
P1476
Pancreatic endocrine tumors ar ...... insulinoma in a NF-1 patient.
@en
P2093
Anja Schmitt
Christoph Schmid
Holger Moch
Matteo Montani
Paul Komminoth
Peter Wiesli
Sonja Schmid
P304
P356
10.1097/00000478-200608000-00018
P407
P50
P577
2006-08-01T00:00:00Z